Ileal Transposition
Ileal transposition is an experimental metabolic operation that moves a segment of lower small bowel higher up so nutrients meet it sooner, triggering gut hormones that improve blood sugar and appetite.
Plain English
Patient-Friendly Explanation
Ileal transposition is an experimental weight and diabetes operation. A short segment of the lower small bowel, the ileum, is detached and reconnected higher up the gut, so food reaches it much sooner than it normally would. Because that part of the bowel releases hormones such as GLP-1 and PYY, the operation produces a strong, early hormone surge that improves blood sugar control and reduces appetite, to a degree that is greater than the weight lost would explain. Unlike gastric bypass, it does not shrink the stomach and does not reroute bile and pancreatic juices, so malabsorption is limited. It is a research procedure rather than a routine clinical option, but it helped establish that the metabolic benefits of surgery come partly from hormone signalling in the gut, not only from restriction or malabsorption.
Medical
Clinical Definition
Ileal transposition is a purely hormonal metabolic procedure in which a roughly 10 to 25 centimetre segment of distal ileum is isolated on its mesenteric blood supply and interposed into the proximal jejunum, so that nutrient contact with L cells occurs early without gastric restriction or intestinal bypass. The result is exaggerated postprandial secretion of GLP-1, peptide YY and oxyntomodulin together with improved insulin sensitivity and secretion, reduced food intake and reduced body weight in animal models and in small human case series, with glycaemic improvements exceeding those expected from weight loss alone; the effect is attributed to early stimulation of incretin-producing L cells and to altered enteroendocrine signalling rather than to restriction or malabsorption. Observations from ileal transposition, together with the duodenal-jejunal bypass limb and bile diversion experiments, underpinned recognition that proximal nutrient exclusion and distal intestinal exposure are independent mechanisms, a principle later applied clinically in the duodenal-jejunal bypass liner, endoscopic duodenal mucosal resurfacing, duodenal switch variants and single-anastomosis duodeno-ileal bypass. The operation is technically demanding and carries risks of anastomotic leak, obstruction, ileal necrosis, internal hernia and micronutrient deficiency, and human evidence is limited to small, largely non-randomised series with short follow-up, so it is not offered as routine weight-management surgery in any guideline. Its current value is mechanistic and experimental, and its historical importance lies in shaping present-day incretin-directed pharmacotherapy and endoluminal metabolic therapies.
Key Insight
Why It Matters
Patients often assume weight-loss operations work only by making the stomach smaller. Ileal transposition showed that rearranging the gut so hormones are released earlier can improve blood sugar and appetite directly, and that insight sits behind the hormone-based treatments used today.
Sources
Reviewed against standard medical references.
Medically reviewed by
Family Physician & Registered Acupuncturist, Accord Medical Clinic. MBBS (NUS), Graduate Diploma in Family Medicine (NUS), Graduate Diploma in Acupuncture (Singapore College of TCM).
Last reviewed: September 2026
This page is general health education, not medical advice. Whether any treatment is appropriate for you is a decision made in consultation after assessment.
